858 — Extrawell Pharmaceutical Holdings Cashflow Statement
0.000.00%
Last trade - 00:00- HK$64.53m
- HK$83.21m
- HK$72.58m
Annual cashflow statement for Extrawell Pharmaceutical Holdings, fiscal year end - March 31st, HKD millions except per share, conversion factor applied.
2019 March 31st | 2020 March 31st | 2021 March 31st | 2022 March 31st | 2023 March 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | HKAS | HKAS | HKAS | HKAS | HKAS |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | 63.4 | 85.5 | -120 | 132 | 131 |
| Depreciation | |||||
| Non-Cash Items | -80.1 | -91.1 | 110 | -145 | -141 |
| Unusual Items | |||||
| Equity in Net Earnings/Losses | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -4.6 | -13.9 | 1.03 | 2.12 | 2.95 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Other Assets | |||||
| Change in Accounts Payable | |||||
| Change in Accrued Expenses | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | -15.1 | -13.3 | -0.852 | -1.77 | 1.18 |
| Capital Expenditures | -1.41 | -0.162 | -0.721 | -9.63 | -6.62 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | 4.53 | -7.14 | 0.677 | 0.252 | -1.82 |
| Sale of Fixed Assets | |||||
| Sale/Maturity of Investment | |||||
| Change in Net Investments | |||||
| Purchase of Investments | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | 3.11 | -7.3 | -0.044 | -9.38 | -8.44 |
| Financing Cash Flow Items | — | -0.033 | -0.212 | -0.135 | -0.092 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | — | -0.241 | -1.9 | -1.94 | -2.39 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | -12.9 | -22.5 | 0.273 | -14.8 | -9.48 |